Asst.Prof.Dr Danita Kannarunimit

Visiting Fellowship-Department of Radiation Oncology
Memorial Sloan Kettering Cancer Center, New York, USA
2012

Research Fellowship
Department of Radiation Oncology, University of California
San Francisco, USA
2011

Residency
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
2010

Doctor of Medicine (First Class Honor)
Faculty of Medicine, King Chulalongkorn Memorial Hospital
Chulalongkorn University, Thailand
2006

Visiting Fellowship of Memorial Sloan Kettering Cancer Center
2013

Research Fellowship of University California
San Francisco
2012

Diploma of The Thai Board of Radiation Oncology
2012

Thai Medical License
2006

JOURNAL ARTICLE  @Technology in cancer research & treatment - Nov 6

Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors: A Comparison of Robotic Radiosurgery, Helical Tomotherapy and Volumetric Modulated Arc Therapy.

Kannarunimit D.;Descovich M.;Garcia A.;Chen J.;Weinberg V.;McGuinness C.;Pinnaduwage D.;Murnane J.;Murnane J.;Gottschalk AR.;Yom SS.
DOI 10.7785/tcrt.2012.500394

Article  @Medical Physics - -

Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: Insights from lung tumor patients treated with robotic radiosurgery

Descovich M.; McGuinness C.; Kannarunimit D.; Chen J.; Pinnaduwage D.; Pouliot J.; Kased N.; Gottschalk A.R.; Yom S.S.
Volume: 42, Issue: 3, Pages: 1280-1287
DOI 10.1118/1.4907956

Article  @Radiation Oncology - -

A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events

Songthong A.P.; Kannarunimit D.; Chakkabat C.; Lertbutsayanukul C.
Volume: 10, Issue: 1
DOI 10.1186/s13014-015-0472-y

Article  @JOURNAL OF RADIATION RESEARCH - JUL

Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
Prayongrat,A;Chakkabat,C;Kannarunimit,D;Hansasuta,P;Lertbutsayanukul,C
Volume: 58, Issue: 4, Pages: 509-516
DOI 10.1093/jrr/rrw128

Article  @Supportive Care in Cancer - -

Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis

Chitapanarux I.; Tungkasamit T.; Petsuksiri J.; Kannarunimit D.; Katanyoo K.; Chakkabat C.; Setakornnukul J.; Wongsrita S.; Jirawatwarakul N.; Lertbusayanukul C.; Sripan P.; Traisathit P.
Volume: 26, Issue: 3, Pages: 879-886
DOI 10.1007/s00520-017-3904-4

Article  @Strahlentherapie und Onkologie - -

A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma [Eine randomisierte Phase-III-Studie für den Vergleich zwischen intensitätsmodulierter Strahlentherapie mit sequenziell oder mit simultan integriertem Boost bei Nasopharynxkarzinom]

Lertbutsayanukul C.; Prayongrat A.; Kannarunimit D.; Chakkabat C.; Netsawang B.; Kitpanit S.
Volume: 194, Issue: 5, Pages: 375-385
DOI 10.1007/s00066-017-1251-5

Article  @JAPANESE JOURNAL OF CLINICAL ONCOLOGY - MAY

Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy
Lertbutsayanukul,C;Kannarunimit,D;Netsawang,B;Kitpanit,S;Chakkabat,C;Hansasuta,P;Prayongrat,A
Volume: 48, Issue: 5, Pages: 467-475
DOI 10.1093/jjco/hyy027

Article  @Japanese journal of clinical oncology - -

Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial

Kitpanit S.; Jittapiromsak N.; Sriyook A.; Prayongrat A.; Kannarunimit D.; Chakkabat C.; Lertbutsayanukul C.
Volume: 49, Issue: 12, Pages: 1100-1113
DOI 10.1093/jjco/hyz109